We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




PCL Alverno to Implement Beckman Coulter's Expertise

By LabMedica International staff writers
Posted on 25 Feb 2014
PCL Alverno Clinical Laboratories (Hammond, IN, USA) and Beckman Coulter Diagnostics (Brea, CA, USA) announced a partnership to create laboratories to better serve patients. More...
Beckman Coulter was awarded an installation agreement by PLC Alverno with the aim of improving the clinical laboratory.

The contract includes a hematology extension of the laboratory network’s current only source agreement, a new Iris urinalysis agreement, AU chemistry instruments, DxI immunoassay instruments, and four automation lines.

PCL Alverno is a full service, community-based medical laboratory performing over 750 tests in both clinical and anatomic pathology. It is joint venture of two distinct Catholic healthcare systems: Presence Health (IL, USA) and Franciscan Alliance (IN, USA). PCL Alverno provides laboratory services for 26 hospitals in Indiana and Illinois and has a large reference lab for outreach work. Its modern state-of-the-art laboratory is a freestanding, local reference lab in its service area. PCL Alverno offers the personal customer service of a local laboratory with the style of a large reference laboratory. PCL Alverno's pathologists are part of the pathology practice of Pathology Consultants, Inc.

Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. PCL Alverno will modernize their laboratories with more than 150 new instruments beginning in 2014, implementing Beckman Coulter’s automation solutions and expertise in workflow processes.

“We are honored that PCL Alverno has chosen to partner with Beckman Coulter Diagnostics to provide solutions that deliver quality results through automation and standardized workflow processes in the laboratory,” said John Nosenzo, senior vice president of Global Customer Operations, Beckman Coulter Diagnostics. “This partnership demonstrates our shared commitment to patient care and allows us the opportunity to jointly advance and optimize the laboratory—the foundation of patient care.”

Related Links:

PCL Alverno Clinical Laboratories
Beckman Coulter Diagnostics



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.